Value of new quinolones in the treatment and prophylaxis of infectious diseases: Introductory remarks
- 1 December 1989
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (12) , 1071-1074
- https://doi.org/10.1007/bf01975173
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fluoroquinolone AntibioticsDrugs, 1988
- Comparative Antibacterial Activity of New Quinolone-Carboxylic Acid DerivativesClinical Infectious Diseases, 1988
- Aspects of Chemistry in the Development of 4-Quinolone Anti- S2 bacterial AgentsClinical Infectious Diseases, 1988
- IntroductionClinical Infectious Diseases, 1988
- CLINICAL USE OF THE QUINOLONESThe Lancet, 1987
- Chiral DNA gyrase inhibitors. 1. Synthesis and antimicrobial activity of the enantiomers of 6-fluoro-7-(1-piperazinyl)-1-(2-trans-phenylcyclopropyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acidJournal of Medicinal Chemistry, 1986
- New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assayJournal of Medicinal Chemistry, 1986
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- DNA Gyrase and the Supercoiling of DNAScience, 1980